PHILIP W. WILLS, PH.D.
CHIEF COMMERCIAL OFFICER
Philip Wills, Chief Commercial Officer at Catalent Cell & Gene Therapy, is a veteran business executive and scientist with nearly two decades of contract manufacturing experience, primarily focused in viral vectors and other complex biologics. After joining Paragon in 2002, Philip held positions of increasing scope and responsibility, including appointments as the Principal Scientist and VP of Business Development. His career began at the University of Maryland and worked in a variety of scientific roles in both the School of Medicine and Cancer Center.
Philip obtained a Bachelor of Arts in Chemistry from Johns Hopkins University and a PhD in Pharmacology from the University of Maryland Medical School.